Literature DB >> 1582419

Nuclease resistant ribozymes with high catalytic activity.

G Paolella1, B S Sproat, A I Lamond.   

Abstract

Hammerhead ribozymes are efficient RNA enzymes characterized by a typical hammerhead secondary structure and a number of conserved bases. Little is known about the role of the ribose-phosphate backbone, although it is obviously important since a DNA molecule with the same base sequence is not a catalyst. Here we describe the synthesis of artificial ribozymes where modified (2'-O-allyl- and 2'-O-methyl-) ribonucleotides substitute for the corresponding ribonucleotides. A systematic analysis of partially substituted polymers identified a minimum set of six non-contiguous positions where insertion of modified ribonucleotides strongly affects catalytic activity. Surprisingly, ribozymes completely substituted except for these six ribonucleotides are still very active. These molecules efficiently cleave in trans target RNAs in a sequence-specific way, but, unlike RNA ribozymes, are very resistant to nuclease degradation and are very stable in serum. These properties make such synthetic polymers potentially useful for in vivo gene expression studies and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582419      PMCID: PMC556650          DOI: 10.1002/j.1460-2075.1992.tb05244.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  23 in total

1.  Antisense probes containing 2-aminoadenosine allow efficient depletion of U5 snRNP from HeLa splicing extracts.

Authors:  G M Lamm; B J Blencowe; B S Sproat; A M Iribarren; U Ryder; A I Lamond
Journal:  Nucleic Acids Res       Date:  1991-06-25       Impact factor: 16.971

2.  Mixed DNA/RNA polymers are cleaved by the hammerhead ribozyme.

Authors:  J H Yang; J P Perreault; D Labuda; N Usman; R Cedergren
Journal:  Biochemistry       Date:  1990-12-25       Impact factor: 3.162

3.  Nuclear magnetic resonance studies of the hammerhead ribozyme domain. Secondary structure formation and magnesium ion dependence.

Authors:  H A Heus; A Pardi
Journal:  J Mol Biol       Date:  1991-01-05       Impact factor: 5.469

4.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  Synthesis and applications of oligoribonucleotides with selected 2'-O-methylation using the 2'-O-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl] protecting group.

Authors:  B Beijer; I Sulston; B S Sproat; P Rider; A I Lamond; P Neuner
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

6.  Sequence requirements of the hammerhead RNA self-cleavage reaction.

Authors:  D E Ruffner; G D Stormo; O C Uhlenbeck
Journal:  Biochemistry       Date:  1990-11-27       Impact factor: 3.162

7.  Relationship between 2'-hydroxyls and magnesium binding in the hammerhead RNA domain: a model for ribozyme catalysis.

Authors:  J P Perreault; D Labuda; N Usman; J H Yang; R Cedergren
Journal:  Biochemistry       Date:  1991-04-23       Impact factor: 3.162

8.  2'-O-alkyl oligoribonucleotides as antisense probes.

Authors:  A M Iribarren; B S Sproat; P Neuner; I Sulston; U Ryder; A I Lamond
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.

Authors:  W A Pieken; D B Olsen; F Benseler; H Aurup; F Eckstein
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

10.  Site-directed ribose methylation identifies 2'-OH groups in polyadenylation substrates critical for AAUAAA recognition and poly(A) addition.

Authors:  V J Bardwell; M Wickens; S Bienroth; W Keller; B S Sproat; A I Lamond
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

View more
  28 in total

1.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

3.  A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.

Authors:  P Hendry; M J McCall; F S Santiago; P A Jennings
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

4.  Efficient cleavage of pre-tRNAs by E. coli RNAse P RNA requires the 2'-hydroxyl of the ribose at the cleavage site.

Authors:  R G Kleineidam; C Pitulle; B Sproat; G Krupp
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

Review 5.  Hammerhead ribozyme kinetics.

Authors:  T K Stage-Zimmermann; O C Uhlenbeck
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

6.  Ion-induced folding of the hammerhead ribozyme: a fluorescence resonance energy transfer study.

Authors:  G S Bassi; A I Murchie; F Walter; R M Clegg; D M Lilley
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

7.  An oligodeoxyribonucleotide that supports catalytic activity in the hammerhead ribozyme domain.

Authors:  P Chartrand; S C Harvey; G Ferbeyre; N Usman; R Cedergren
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.

Authors:  S M Gryaznov; H Winter
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

9.  Enzymatic synthesis of 2'-modified nucleic acids: identification of important phosphate and ribose moieties in RNase P substrates.

Authors:  F Conrad; A Hanne; R K Gaur; G Krupp
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

10.  Translation of 2'-modified mRNA in vitro and in vivo.

Authors:  H Aurup; A Siebert; F Benseler; D Williams; F Eckstein
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.